Phathom pharmaceuticals announces inducement grants under nasdaq listing rule 5635(c)(4)

Florham park, n.j., may 01, 2025 (globe newswire) -- phathom pharmaceuticals, inc. (nasdaq: phat), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (gi) diseases, today announced that, in connection with the appointment of jonathan bentley as senior vice president, head of sales, the company's board of directors has approved the grant of inducement awards.
NDAQ Ratings Summary
NDAQ Quant Ranking